Hidden clues in prostate cancer – Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratification

Volume: 524, Pages: 182 - 192
Published: Jan 1, 2022
Abstract
The heterogeneity of prostate cancer is evident at clinical, morphological and molecular levels. To aid clinical decision making, a three-tiered system for risk stratification is used to designate low-, intermediate-, and high-risk of disease progression. Intermediate-risk prostate cancers are the most frequently diagnosed, and even with common diagnostic features, can exhibit vastly different clinical progression. Thus, improved risk...
Paper Details
Title
Hidden clues in prostate cancer – Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratification
Published Date
Jan 1, 2022
Volume
524
Pages
182 - 192
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.